Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycloserine for postoperative pain after lumbar disc herniation surgery
IRCT20200115046150N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Mar 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain, Neuralgia and Herniated Lumbar Disk comparing Cycloserine with Placebo (2 arms). Primary endpoints: lumbar pain and morphine intake. Started Mar 2020; status: completed.
02
Drugs
d-cycloserine
03
Conditions
postoperative painNeuralgiaHerniated Lumbar Disk
Beyond the preview
Go deeper on IRCT20200115046150N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200115046150N1.